| Drug General Information |
| Drug ID |
D03QMR
|
| Former ID |
DNC003793
|
| Drug Name |
WB-4101
|
| Drug Type |
Small molecular drug
|
| Indication |
Discovery agent
|
Terminated |
[1],
[2]
|
|---|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C19H23NO5
|
| InChI |
InChI=1S/C19H23NO5/c1-21-17-8-5-9-18(22-2)19(17)23-11-10-20-12-14-13-24-15-6-3-4-7-16(15)25-14/h3-9,14,20H,10-13H2,1-2H3
|
| InChIKey |
GYSZUJHYXCZAKI-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
5455582, 8153486, 11364724, 11367286, 11369848, 11371810, 11374784, 11378012, 11485246, 11489391, 11490601, 11493027, 11495629, 12012584, 14778240, 26751986, 29224722, 47589181, 47810969, 48185182, 50070270, 50070940, 50104662, 57322893, 80424907, 85209354, 85789607, 90341701, 92729686, 103094355, 103155021, 103194723, 103921864, 104309956, 117603566, 124749631, 124879832, 124879833, 126408198, 128025709, 134340998, 135061510, 135208365, 135610556, 135651323, 179039392, 227079672, 252647768
|
| Target and Pathway |
| Target(s) |
Alpha-1B adrenergic receptor |
Target Info |
Inhibitor |
[3]
|
|---|
| Alpha-2A adrenergic receptor |
Target Info |
Inhibitor |
[4]
|
| 5-hydroxytryptamine 1A receptor |
Target Info |
Inhibitor |
[5]
|
| Alpha-2C adrenergic receptor |
Target Info |
Inhibitor |
[4]
|
| Alpha-2B adrenergic receptor |
Target Info |
Inhibitor |
[4]
|
| Alpha-1A adrenergic receptor |
Target Info |
Inhibitor |
[3]
|
| Alpha-1D adrenergic receptor |
Target Info |
Inhibitor |
[3]
|
|
KEGG Pathway
|
Calcium signaling pathway
|
|
cGMP-PKG signaling pathway
|
|
Neuroactive ligand-receptor interaction
|
|
Adrenergic signaling in cardiomyocytes
|
|
Vascular smooth muscle contraction
|
|
Salivary secretionhsa04022:cGMP-PKG signaling pathway
|
|
Neuroactive ligand-receptor interactionhsa04024:cAMP signaling pathway
|
|
Serotonergic synapsehsa04022:cGMP-PKG signaling pathway
|
|
Neuroactive ligand-receptor interactionhsa04022:cGMP-PKG signaling pathway
|
|
Neuroactive ligand-receptor interactionhsa04020:Calcium signaling pathway
|
|
AMPK signaling pathway
|
|
Salivary secretionhsa04020:Calcium signaling pathway
|
|
Salivary secretion
|
|
NetPath Pathway
|
IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway
|
|
PANTHER Pathway
|
Alpha adrenergic receptor signaling pathwayP00002:Alpha adrenergic receptor signaling pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
|
5HT1 type receptor mediated signaling pathwayP00002:Alpha adrenergic receptor signaling pathway
|
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathwayP00002:Alpha adrenergic receptor signaling pathway
|
|
Pathway Interaction Database
|
LPA receptor mediated events
|
|
Reactome
|
Adrenoceptors
|
|
G alpha (q) signalling events
|
|
G alpha (12/13) signalling eventsR-HSA-390696:Adrenoceptors
|
|
Adrenaline signalling through Alpha-2 adrenergic receptor
|
|
Adrenaline,noradrenaline inhibits insulin secretion
|
|
G alpha (i) signalling events
|
|
G alpha (z) signalling events
|
|
Surfactant metabolismR-HSA-390666:Serotonin receptors
|
|
G alpha (i) signalling eventsR-HSA-390696:Adrenoceptors
|
|
Surfactant metabolismR-HSA-390696:Adrenoceptors
|
|
G alpha (z) signalling eventsR-HSA-390696:Adrenoceptors
|
|
G alpha (12/13) signalling events
|
|
WikiPathways
|
Monoamine GPCRs
|
|
Calcium Regulation in the Cardiac Cell
|
|
GPCRs, Class A Rhodopsin-like
|
|
Vitamin D Receptor Pathway
|
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
|
GPCR ligand binding
|
|
GPCR downstream signaling
|
|
AMPK SignalingWP58:Monoamine GPCRs
|
|
Platelet Aggregation (Plug Formation)
|
|
Integration of energy metabolism
|
|
GPCR downstream signalingWP722:Serotonin HTR1 Group and FOS Pathway
|
|
SIDS Susceptibility Pathways
|
|
GPCR downstream signalingWP58:Monoamine GPCRs
|
|
Endothelin Pathways
|
|
GPCRs, Other
|
| References |
| REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 499). |
|---|
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004048) |
|---|
| REF 3 | J Med Chem. 1995 Sep 1;38(18):3415-44.Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification. |
|---|
| REF 4 | J Med Chem. 1982 Dec;25(12):1389-401.alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. |
|---|
| REF 5 | J Med Chem. 1993 Oct 15;36(21):3161-5.Synthesis of (R,S)-trans-8-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'-propenyl)amino]tetral in (trans-8-OH-PIPAT): a new 5-HT1A receptor ligand. |
|---|
